In addition to the IL2 gene itself, CREMα influences gene expression of factors that regulate IL-2 expression. CREMα binds to and represses the promoter of the proto-oncogene c-fos in T cells from SLE patients, resulting in reduced activity of the transcription factor AP-1, which, under physiological conditions, activates IL2 gene transcription [33].
